213 related articles for article (PubMed ID: 27756417)
1. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
[TBL] [Abstract][Full Text] [Related]
2. A new delineation method research of the clinical target volume for pancreatic cancer adjuvant radiotherapy.
Zhang TT; Wei L; Yuan GW; Zhao DQ; Zhang ML; Zhang GF; Wang PC
Cancer Radiother; 2019 Jun; 23(3):201-208. PubMed ID: 31101540
[TBL] [Abstract][Full Text] [Related]
3. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence map to guide target volume delineation after radical prostatectomy.
Wang J; Kudchadker R; Choi S; Pettaway CA; Choi H; Hobbs BD; Occena MC; McGuire SE; Pugh TJ; Hoffman K; Mahmood U; Kuban DA
Pract Radiat Oncol; 2014; 4(6):e239-46. PubMed ID: 25407875
[TBL] [Abstract][Full Text] [Related]
5. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
[TBL] [Abstract][Full Text] [Related]
6. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
10. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles.
Zhu X; Cao Y; Ju X; Zhao X; Jiang L; Ye Y; Shen Y; Cao F; Qing S; Zhang H
Cancer Sci; 2021 Jan; 112(1):287-295. PubMed ID: 32418280
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
[TBL] [Abstract][Full Text] [Related]
12. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.
Miralbell R; Vees H; Lozano J; Khan H; Mollà M; Hidalgo A; Linero D; Rouzaud M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):356-61. PubMed ID: 17236961
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy in prostate cancer: the case of the missing target.
Croke J; Malone S; Roustan Delatour N; Belanger E; Avruch L; Morash C; Kayser C; Underhill K; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1160-8. PubMed ID: 22270169
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
Zhu X; Ju X; Cao Y; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):101-110. PubMed ID: 30684663
[TBL] [Abstract][Full Text] [Related]
16. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.
Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715
[TBL] [Abstract][Full Text] [Related]
17. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
Zschaeck S; Blümke B; Wust P; Kaul D; Bahra M; Riess H; Klein F; Sinn M; Pelzer U; Budach V; Ghadjar P
PLoS One; 2017; 12(10):e0186341. PubMed ID: 29023527
[TBL] [Abstract][Full Text] [Related]
18. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
19. Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.
Yu W; Hu C; Shui Y; Wu K; Zhang L; Chen Y; Li C; Xu J; Wei Q
BMC Cancer; 2019 Nov; 19(1):1108. PubMed ID: 31727017
[TBL] [Abstract][Full Text] [Related]
20. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
